TELA Bio Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, TELA Bio stock has a consensus rating of "Buy" and an average price target of $2.25. The average 1-year stock price forecast is 181.25% higher than the current stock price, while the lowest is $1.00 (+25.00%) and the highest is $3.25 (+306.25%).

Price Target: $2.25 (+181.25%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$2.25	$2.00	$3.25
Change	+25.00%	+181.25%	+150.00%	+306.25%

* Price targets were last updated on May 13, 2026.

Analyst Ratings

The average analyst rating for TELA Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Aug '25	Nov '25	Dec '25	Mar '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Buy Reiterates $2	Buy	Reiterates	$2	+150.00%	May 13, 2026
Caitlin Roberts Canaccord Genuity	Canaccord Genuity	Buy Maintains $2	Buy	Maintains	$2	+150.00%	May 13, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Hold Reiterates $1	Hold	Reiterates	$1	+25.00%	May 13, 2026
David Turkaly Citizens JMP	Citizens JMP	Buy Maintains $5 → $3	Buy	Maintains	$5 → $3	+275.00%	Mar 27, 2026

Financial Forecast

Revenue This Year

86.71M

from 80.28M

8.01%

from 80.28M

Revenue Next Year

95.73M

from 86.71M

10.40%

from 86.71M

EPS This Year

-0.67

from -0.83

EPS Next Year

-0.56

from -0.67

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	29.46M	41.42M	58.45M	69.30M	80.28M	86.71M
Revenue Growth	61.77%	40.58%	41.13%	18.56%	15.84%	8.01%
Gross Profit	19.12M	27.85M	40.49M	46.87M	54.72M	58.68M
Gross Margin	64.88%	67.24%	69.27%	67.63%	68.17%	67.68%
Operating Income	-29.45M	-39.01M	-44.08M	-41.70M	-33.76M	-32.82M
Net Income	-33.28M	-44.30M	-46.66M	-37.84M	-38.83M	-38.51M
EPS	-	-	-	-	-0.83	-0.67
Free Cash Flow	-19.41M	-27.42M	-25.81M	-26.73M	-16.95M	-37.50M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	87.0M
Avg	86.7M
Low	86.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	8.4%
Avg	8.0%
Low	7.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.67
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-